Moderna
MRNA
#1162
Rank
HK$151.57 B
Marketcap
HK$382.21
Share price
-0.87%
Change (1 day)
91.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2025 : HK$10.22 Billion

According to Moderna 's latest financial reports the company's total debt is HK$10.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2025-12-31HK$10.15 B75.08%
2024-12-31HK$5.79 B-40.26%
2023-12-31HK$9.70 B3.54%
2022-12-31HK$9.37 B31.27%
2021-12-31HK$7.14 B288.76%
2020-12-31HK$1.83 B78.23%
2019-12-31HK$1.03 B293.09%
2018-12-31HK$0.26 B113.97%
2017-12-31HK$0.12 B26.44%
2016-12-31HK$96.93 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$375.64 B 3,573.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$277.24 B 2,610.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$386.66 B 3,680.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$10.97 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.14 B-98.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$10.01 B-2.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$2.45 B-76.03%๐Ÿ‡บ๐Ÿ‡ธ USA